APA (7th ed.) Citation

Smolders, E., Pape, S., de Kanter, C., van den Berg, A., Drenth, J., & Burger, D. (2017). Decreased tacrolimus plasma concentrations during HCV therapy: A drug–drug interaction or is there an alternative explanation? International Journal of Antimicrobial Agents, 49(3), 379. https://doi.org/10.1016/j.ijantimicag.2016.12.004

Chicago Style (17th ed.) Citation

Smolders, E.J, S. Pape, C.T.M.M de Kanter, A.P van den Berg, J.P.H Drenth, and D.M Burger. "Decreased Tacrolimus Plasma Concentrations During HCV Therapy: A Drug–drug Interaction or Is There an Alternative Explanation?" International Journal of Antimicrobial Agents 49, no. 3 (2017): 379. https://doi.org/10.1016/j.ijantimicag.2016.12.004.

MLA (9th ed.) Citation

Smolders, E.J, et al. "Decreased Tacrolimus Plasma Concentrations During HCV Therapy: A Drug–drug Interaction or Is There an Alternative Explanation?" International Journal of Antimicrobial Agents, vol. 49, no. 3, 2017, p. 379, https://doi.org/10.1016/j.ijantimicag.2016.12.004.